A Current Pharmacologic Agent Versus the Promise of Next Generation Therapeutics to Ameliorate Protein Misfolding and/or Aggregation Diseases

Current Opinion in Chemical Biology - Netherlands
doi 10.1016/j.cbpa.2016.01.009
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Protein Misfolding and Aggregation as a Therapeutic Target for Polyglutamine Diseases

Brain Sciences
Neuroscience
2017English

Protein Misfolding Diseases

The Open Biology Journal
2009English

Next-Generation Direct-Acting Influenza Therapeutics

Translational Research
BiochemistryPublic HealthEnvironmentalMedicinePhysiologyOccupational Health
2020English

A-Synuclein Multistate Folding Thermodynamics: Implications for Protein Misfolding and Aggregation

English

Peptide‐based Molecular Strategies to Interfere With Protein Misfolding, Aggregation, and Cell Degeneration

Angewandte Chemie
2019English

Peptide-Based Molecular Strategies to Interfere With Protein Misfolding, Aggregation, and Cell Degeneration

Angewandte Chemie - International Edition
CatalysisChemistry
2020English

Propagated Protein Misfolding: New Opportunities for Therapeutics, New Public Health Risk

Canada Communicable Disease Report
2015English

Protein Misfolding in Neurodegenerative Diseases. Mechanisms and Therapeutic Strategies

Biochemistry (Moscow)
BiochemistryMedicine
2008English

A Revisited Folding Reporter for Quantitative Assay of Protein Misfolding and Aggregation in Mammalian Cells

Biotechnology Journal
Applied MicrobiologyBiotechnologyMolecular MedicineMedicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy